You can buy or sell Celcuity and other stocks, options, ETFs, and crypto commission-free!
Celcuity Inc. Common Stock, also called Celcuity, is cellular analysis company. Read More The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded in January 2012 by Brian Sullivan and Lance Laing and is headquartered in Minneapolis, MN.
52 Week High
52 Week Low
-$0.19 per share
-$0.15 per share